- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Metropolis Healthcare delivered strong Q1FY27 results: Revenue up 17% to ₹450 Cr, EBITDA up 27% to ₹113 Cr, and PAT up 26% to ₹57 Cr. Robust patient/test volume growth (+10-11%) and 210 bps EBITDA margin expansion highlight quality performance across segments and geographies.